TikTok and YouTube Face Fresh Scrutiny from UK Regulator Over Child Safety Concerns US Charges Cubas Ral Castro with Murder Potential Geopolitical and Economic Implications First US FUSB Q1 2026 Earnings EPS 033 In Line with Estimates Global Oil Crisis Government Inaction Raises Concerns Top Economists Forecast Inflation to Reach 6 in Q2 Amid Persistent Price Pressures A O Smith Shares Draw Mixed Analyst Ratings As Market Assesses Growth Prospects SK Hynix Posts Record Profit as AI Chip Demand Surges in Q4 2024 US GDP Rose at 2 Annual Rate in First Quarter Signaling Rebound Broadcom Meta Lead 125M Semiconductor Research Hub at UCLA China Confirms Order for 200 Boeing Aircraft Signaling Renewed Trade Cooperation My Size Inc MYSZ Q4 2025 Earnings Large EPS Miss Overshadowed by Modest Stock Gain SNES Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Gain ASO Q1 2026 Earnings EPS Misses Estimates but Stock Gains 29 GRWG Q1 2026 Earnings Narrow EPS Beat Highlights Cost Discipline Amidst Market Challenges TransAct Technologies TACT Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates by Wide Margin ORA Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance AST SpaceMobile ASTS Rallies 13 Approaches Key Resistance Estrella Immunopharma ESLA Gains 265 as Shares Find NearTerm Support at 11 NACCO Industries NC Gains 157 as Stock Tests Key Resistance Levels Grayscale Avalanche Staking ETF GAVA Climbs 175 as Price Approaches Key Resistance GPGI Inc GPGI Advances 145Holding Above Key Support as Resistance Nears Acurx Pharmaceuticals ACXP Holds Near Key Support as Small Decline Signals Consolidation Codere Online Warrants CDROW Hold Steady at 075 as Consolidation Continues Krystal Biotech KRYS Edges Higher Key Support and Resistance Levels in Focus ClearPoint Neuro CLPT Slips 222 as NearTerm Resistance Holds at 1201 Korro Bio Inc KRRO Surges 62 as Biotech Stock Tests Key Resistance at 1295 Nationwide Faces Governance Concerns as Labour MP Raises Issues Before AGM LVWR Q1 2026 Earnings Net Loss of 009 Per Share No Revenue Disclosed Stock Declines CAMP4 Therapeutics CAMP Rallies 25 Approaching Key Resistance Level